TD Private Client Wealth LLC cut its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 43,525 shares of the company’s stock after selling 145 shares during the quarter. TD Private Client Wealth LLC’s holdings in Procter & Gamble were worth $7,539,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble in the 2nd quarter worth approximately $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of Procter & Gamble during the 3rd quarter valued at $33,000. POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble in the second quarter worth about $34,000. Finally, Quest Partners LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insider Buying and Selling at Procter & Gamble
In related news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. The trade was a 3.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 83,080 shares of company stock valued at $14,629,038 in the last ninety days. Corporate insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same period in the previous year, the firm earned $1.83 earnings per share. Procter & Gamble’s quarterly revenue was down .6% compared to the same quarter last year. As a group, analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.34%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on PG shares. DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and raised their target price for the company from $160.00 to $209.00 in a research note on Monday, November 25th. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. JPMorgan Chase & Co. raised their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Morgan Stanley increased their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Finally, DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a report on Thursday, August 29th. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $180.45.
Read Our Latest Report on Procter & Gamble
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Read More
- Five stocks we like better than Procter & Gamble
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why MongoDB’s Drop Could Be Your Best Buy Opportunity for 2025
- What is a support level?
- 2 AI Stocks That Gap and Crapped for a Dip Buying Opportunity
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 4 Stocks Planning to Return Capital With Hefty Buyback Programs
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.